信邦制药(002390) - 2021 Q3 - 季度财报

Revenue and Profitability - The company's revenue for Q3 2021 was ¥1,624,825,595.25, representing a 3.03% increase year-over-year[4] - Net profit attributable to shareholders decreased by 34.32% to ¥57,447,663.58 for the quarter, while year-to-date net profit increased by 70.50% to ¥210,077,765.52[4] - Basic earnings per share for Q3 2021 was ¥0.03, a decrease of 50.00% year-over-year[4] - Total operating revenue for the period reached CNY 4,723,072,877.26, an increase from CNY 4,279,538,660.95 in the previous period, representing a growth of approximately 10.35%[29] - Net profit for the period was CNY 242,580,888.16, compared to CNY 147,218,380.10 in the previous period, reflecting a growth of approximately 64.7%[32] - The net profit attributable to the parent company was approximately ¥210.08 million, an increase from ¥123.21 million in the previous period, representing a growth of 70.4%[35] - The total comprehensive income attributable to the parent company was approximately ¥210.08 million, compared to ¥123.93 million in the previous period, reflecting a growth of 69.5%[35] - Basic and diluted earnings per share increased to ¥0.12 from ¥0.08, marking a 50% increase[35] Cash Flow and Investments - The net cash flow from operating activities for the year-to-date period was ¥286,409,121.63, down 44.55% compared to the previous year[4] - Cash flow from operating activities generated a net amount of approximately ¥286.41 million, down from ¥516.56 million in the previous period, indicating a decrease of 44.4%[39] - Cash inflow from investment activities totaled approximately ¥1.52 billion, up from ¥1.02 billion in the previous period, showing an increase of 49.5%[41] - Cash outflow from investment activities was approximately ¥2.14 billion, compared to ¥956.07 million in the previous period, indicating a significant increase of 124.1%[41] - Cash flow from financing activities resulted in a net outflow of approximately ¥589.27 million, compared to a net outflow of ¥179.09 million in the previous period[41] - The company received cash from financing activities totaling approximately ¥3.40 billion, an increase from ¥2.71 billion in the previous period, representing a growth of 25.5%[41] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,610,148,053.62, a decrease of 0.54% from the end of the previous year[4] - Total current assets amounted to approximately 6.09 billion, with accounts receivable at about 2.41 billion and inventory at approximately 843.39 million[45] - Total liabilities decreased to CNY 2,802,684,074.40 from CNY 4,493,670,289.51, a significant reduction of approximately 37.6%[27] - Total liabilities reached approximately 4.49 billion, with current liabilities accounting for about 4.47 billion, including short-term borrowings of 3.38 billion[48] - Owner's equity totaled approximately 5.17 billion, with total equity attributable to shareholders at about 4.92 billion[51] Shareholder Information - The total number of common shareholders at the end of the reporting period was 47,415[11] - Guizhou Jinyu Industrial Investment Partnership holds 17.76% of shares, totaling 360,000,000 shares[11] - Harbin Yuxi Venture Capital holds 17.70% of shares, totaling 358,764,349 shares, with all shares pledged[11] - The company's total share capital increased from 1,667,228,611 shares to 2,027,228,611 shares after a private placement of 36,000,000 shares[15] Research and Development - Research and development expenses decreased by 92.89% to ¥745,793.00 due to the exclusion of a subsidiary from consolidation[7] - Research and development expenses for the period were CNY 745,793.00, a significant decrease from CNY 10,493,462.96 in the previous period[32] Other Income and Expenses - Other income increased by 79.87% to ¥9,001,421.25, primarily due to increased government subsidies[7] - The company reported a significant increase in non-operating income of 1347.42% to ¥6,820,264.81, attributed to the recovery of previously uncollectible amounts[10] - The company experienced a 341.76% increase in non-operating expenses to ¥31,580,383.06, mainly due to increased donations[10] Management and Governance - The company underwent a change in its board of directors and management team, completing the transition on July 15, 2021[16] - The company has not undergone an audit for the third quarter report, which may affect the reliability of the financial data presented[53] Other Financial Metrics - The company reported a decrease in long-term prepaid expenses by approximately 21.05 million, indicating improved cost management[51] - The company has recognized an increase in right-of-use assets by approximately 45.59 million due to the implementation of new leasing standards[52] - The company has a total of 188.19 million in notes payable and 600.38 million in accounts payable, reflecting its operational liabilities[48] - The company has a total of 39.62 million in contract liabilities, indicating future revenue obligations[48] - The company reported a total of 27.96 million in undistributed profits, contributing to its retained earnings[51]